While studies have suggested that increased AEA concentrations might have an antidepressant and anxiolytic effect in both animal and human models [73–75], in obesity with BE, the CB1R blockade has shown effects in reducing food intake and, even, weight and adiposity [47, 76]. The gene discussed is CNR1; the disease is obesity disorder.